PATENT CLAIM ANALYSIS

Application Number: 16124069
Application Type: Utility
Filing Date: 2018-09
Publication Date: 2019-01
Patent Classification: ["514", "108000"]

Abstract:
Oral dosage forms of osteoclast inhibitors, such as zoledronic acid, in an acid or a salt form can be used to treat or alleviate pain or related conditions.

Claim (Index 12):
The method of  claim 10 , wherein the dosage form contains about 50 mg to about 150 mg of the zoledronic acid in the salt form.

Metadata:
- Claim Count in Document: 38.0
- Percentile: 97.0
- Lexical Diversity: 1.14815
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15403073', '15439774', '15416995', '15697267', '15897947']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8591627271991822
- 35 USC 102 Novelty (BERT): 0.6163600609675605
- Combined Prediction Score: 0.83488246057602
- Mean Citation Score: 640.224188
- Max Citation Score: 644.8831
- Similarity Product: 484.6411878235221

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test